Aimed Bio Inc. (KOSDAQ:0009K0)

South Korea flag South Korea · Delayed Price · Currency is KRW
54,900
-800 (-1.44%)
At close: Jan 16, 2026
24.77%
Market Cap3.46T
Revenue (ttm)29.65B
Net Income (ttm)-43.02B
Shares Out64.16M
EPS (ttm)-1,065.74
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume640,024
Average Volume1,284,289
Open54,700
Previous Close55,700
Day's Range52,800 - 58,500
52-Week Range42,000 - 80,200
Betan/a
RSI50.63
Earnings Daten/a

About Aimed Bio

Aimed Bio Inc. develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases. Its multidisciplinary platform offers antibody-drug conjugates, blood-brain barrier penetration, brain immune modulation, and patient-derived models (PDC/PDX). Aimed Bio Inc. was founded in 2018 and is based in Seoul, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2018
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 0009K0
Full Company Profile

Financial Performance

In 2024, Aimed Bio's revenue was 11.76 billion, an increase of 6768.70% compared to the previous year's 171.21 million. Losses were -3.30 billion, -63.38% less than in 2023.

Financial Statements

News

There is no news available yet.